Merrimack Pharmaceuticals, Inc. (MACK)
- Previous Close
14.73 - Open
14.71 - Bid 14.69 x 500
- Ask 14.74 x 100
- Day's Range
14.71 - 14.77 - 52 Week Range
11.53 - 15.89 - Volume
105,981 - Avg. Volume
131,558 - Market Cap (intraday)
213.763M - Beta (5Y Monthly) 1.43
- PE Ratio (TTM)
-- - EPS (TTM)
-0.08 - Earnings Date May 2, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 13, 2019
- 1y Target Est
--
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
www.merrimack.comRecent News: MACK
Performance Overview: MACK
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MACK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MACK
Valuation Measures
Market Cap
213.76M
Enterprise Value
194.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
11.40
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-89.56
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-6.97%
Return on Equity (ttm)
-6.22%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.18M
Diluted EPS (ttm)
-0.08
Balance Sheet and Cash Flow
Total Cash (mrq)
18.88M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.13M